About · The publisher and the method
An independent reading room for the GHK-Cu copper-peptide literature
What this site is, what it is not, and how each capsule of evidence gets sourced before it is published.
What this site is
Telehealth GHK-Cu is an independent editorial project that publishes plain-language summaries of the peer-reviewed research literature on GHK-Cu, the copper-binding tripeptide also known as Copper Tripeptide-1. We are not a clinic. We do not employ clinicians and we do not provide medical advice. We do not manufacture, sell, or distribute any product. Our work is editorial commentary on publicly available science.
The site is organized around a single idea borrowed from the molecule's own consumer life: the copper-peptide literature is unusually chunkable into discrete, labelled findings — a hair-count delta, a procollagen comparison, a peak-collagen concentration, a gene-modulation percentage, a copper stability constant. We render each of those as a clean capsule, with the dealt hair-follicle research leading and the collagen, gene-expression and wound-repair record following.
What 'telehealth' means here — and what it does not
The word "telehealth" in this site's name is editorial framing, not a service claim. It describes the register we write in — accessible, modern, the way a well-built wellness app explains a concept — not a clinic, a consultation, a prescription pad or a checkout. We do not offer telehealth appointments, we do not connect anyone to a prescriber, and nothing on this site is for sale.
We are explicit about this because the distinction is easy to blur. A reader arriving on a copper-peptide page deserves to know immediately whether they are reading marketing, a medical service, or independent commentary. This is the third. The position we occupy is that of a publisher standing next to the literature and reading it carefully, not a provider standing between a reader and a treatment.
How we handle the evidence
Every quantitative claim on this site — every dose, percentage, n-value, half-life and effect size — maps to a numbered citation drawn from the published record, and those citations are listed in full on the references page. We describe what was administered to which species at which concentration by which route; we do not translate any of it into a human dosing recommendation, because GHK-Cu's systemic use is unapproved and has no validated human pharmacokinetic basis [6].
We also try to be honest about the shape of the evidence. The strongest data are topical and dermatologic [3]. The hair regrowth signal comes from a combination formulation, not pure GHK-Cu [4]. Some follicle-level work uses an analog, AHK-Cu, rather than GHK-Cu itself [8]. And much of the foundational mechanistic literature traces to a single investigator, so independent replication of the broadest claims is still limited. Where the evidence is strong we say so plainly; where it thins, we tag the gap rather than paper over it.